1Hoshino K,Takeuchi O,Kawai T,et al.Cutting edge: Toll - like receptor 4 ( TLR4 ) - dificient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product[].J immunol.1999
2Onishi HR,Pelak BA,Gerckens LS,et al.Antibacterial agents that inhibit lipid A biosynthesis[].Science.1996
3Lerch PG,Fortsch V,Hodler G,et al.Production and characterization of a reconstituted high density lipoprotein for the therapeutic applications[].Vox Sanguinis.1996
4Nemoto H,Nakamoto H,Odada H,et al.Newly developed immobilized polymyxin b fibers improve the survival of patients with sepsis[].Blood Purification.2001
5Bunnel E,Lynn M,Habet K,et al.A Lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia[].Critical Care Medicine.2000
6Chow JC,Young DW,Goleubock DT,et al.Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction[].Journal of Biological Chemistry.1999
7Gudmundsson GH,Agerberth B,Odeberg J,et al.The human gene FALL39and processing of the Cathilin precursor to the antibacterial peptide LL-37 in granulocytes[].European Journal of Biochemistry.1996
8Haas CJ,Zee R,Benaissa-Trouw B,et al.Lipopolysaccharide (LBS) -bingding synthetic peptides derived from serum amyloid P component neuftralize LPS[].Infection and Immunity.1999
9Le Roy D,Di Padova F,Tees R,et al.Monoclonal antibodies to murine lipopolysaccharide ( LPS)-binding protein ( LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14[].J Immunol.1999
10Giroir BP,Scannon PJ,Levin M.Bactericidal/permeability increasing proteinlessons learned from phase Ⅲ, randomized,clinical trial of rBP121 for adjunctive treatmemt of children with severe menigococcemia[].Critical Care Medicine.2001
